Bridgeway Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $163K | Buy |
+37,836
| New | +$163K | ﹤0.01% | 1001 |
|
|
2025
Q1 | – | Sell |
-15,967
| Closed | -$162K | – | 1222 |
|
|
2024
Q4 | $162K | Hold |
15,967
| – | – | ﹤0.01% | 1042 |
|
|
2024
Q3 | $199K | Sell |
15,967
-1,666
| -9% | -$20.7K | ﹤0.01% | 1069 |
|
|
2024
Q2 | $229K | Buy |
17,633
+5,000
| +40% | +$65.1K | 0.01% | 1026 |
|
|
2024
Q1 | $286K | Sell |
12,633
-6,667
| -35% | -$151K | 0.01% | 1047 |
|
|
2023
Q4 | $250K | Hold |
19,300
| – | – | 0.01% | 1090 |
|
|
2023
Q3 | $388K | Buy |
+19,300
| New | +$388K | 0.01% | 952 |
|